Cargando…

Novel Zinc(II) and Copper(II) Complexes of 2-((2-Hydroxyethyl)amino)quinoline-3-carbaldehyde for Antibacterial and Antioxidant Activities: A Combined Experimental, DFT, and Docking Studies

[Image: see text] In the present work, two novel complexes of zinc(II) and copper(II) were synthesized from the ligand 2-((2-hydroxyethyl)amino)quinoline-3-carbaldehyde (H(2)L) in a 1:2 metal-to-ligand ratio in methanol. The complexes were characterized by UV–visible spectroscopy, fluorescence spect...

Descripción completa

Detalles Bibliográficos
Autores principales: Damena, Tadewos, Alem, Mamaru Bitew, Zeleke, Digafie, Desalegn, Tegene, Eswaramoorthy, Rajalakshmanan, Demissie, Taye B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352163/
https://www.ncbi.nlm.nih.gov/pubmed/35936450
http://dx.doi.org/10.1021/acsomega.2c02205
_version_ 1784762593726955520
author Damena, Tadewos
Alem, Mamaru Bitew
Zeleke, Digafie
Desalegn, Tegene
Eswaramoorthy, Rajalakshmanan
Demissie, Taye B.
author_facet Damena, Tadewos
Alem, Mamaru Bitew
Zeleke, Digafie
Desalegn, Tegene
Eswaramoorthy, Rajalakshmanan
Demissie, Taye B.
author_sort Damena, Tadewos
collection PubMed
description [Image: see text] In the present work, two novel complexes of zinc(II) and copper(II) were synthesized from the ligand 2-((2-hydroxyethyl)amino)quinoline-3-carbaldehyde (H(2)L) in a 1:2 metal-to-ligand ratio in methanol. The complexes were characterized by UV–visible spectroscopy, fluorescence spectroscopy, Fourier transform infrared (FT-IR) spectroscopy, powder X-ray diffraction (XRD), scanning electron microscopy-energy-dispersive X-ray spectroscopy (SEM-EDX), mass spectrometry (MS), nuclear magnetic resonance (NMR) spectroscopy, and thermogravimetric analysis (TGA) experimental techniques and density functional theory (DFT) calculations. The spectral data revealed that the mono-deprotonated (HL) ligand acted as a bidentate ligand, which bound to both Zn(II) and Cu(II) ions via the nitrogen atom of the amine (N–H) and the hydroxyl (O–H) groups through the deprotonated oxygen atom. Formation constants and thermal analysis indicated that both metal complexes are stable up to 100 °C with thermodynamically favored chemical reactions. The Cu(II) complex showed antibacterial activities with the zones of inhibition of 20.90 ± 2.00 mm against Pseudomonas aeruginosa, 19.69 ± 0.71 mm against Staphylococcus aureus, and 18.58 ± 1.04 mm against Streptococcus pyogenes. These results are relatively higher compared with the Zn(II) complex at the same concentration. The minimum inhibitory concentration (MIC) results for the complexes also showed similar trends against the three bacteria. On the other hand, radical scavenging activities of both Cu(II) and Zn(II) complexes showed half-maximal inhibitory concentrations (IC(50)) of 4.72 and 8.2 μg/mL, respectively, while ascorbic acid (a positive control) has a value of 4.28 μg/mL. The Cu(II) complex exhibited better communication with the positive control, indicating its potential use for biological activities. The calculated and in silico molecular docking results also strongly support the experimental results.
format Online
Article
Text
id pubmed-9352163
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-93521632022-08-05 Novel Zinc(II) and Copper(II) Complexes of 2-((2-Hydroxyethyl)amino)quinoline-3-carbaldehyde for Antibacterial and Antioxidant Activities: A Combined Experimental, DFT, and Docking Studies Damena, Tadewos Alem, Mamaru Bitew Zeleke, Digafie Desalegn, Tegene Eswaramoorthy, Rajalakshmanan Demissie, Taye B. ACS Omega [Image: see text] In the present work, two novel complexes of zinc(II) and copper(II) were synthesized from the ligand 2-((2-hydroxyethyl)amino)quinoline-3-carbaldehyde (H(2)L) in a 1:2 metal-to-ligand ratio in methanol. The complexes were characterized by UV–visible spectroscopy, fluorescence spectroscopy, Fourier transform infrared (FT-IR) spectroscopy, powder X-ray diffraction (XRD), scanning electron microscopy-energy-dispersive X-ray spectroscopy (SEM-EDX), mass spectrometry (MS), nuclear magnetic resonance (NMR) spectroscopy, and thermogravimetric analysis (TGA) experimental techniques and density functional theory (DFT) calculations. The spectral data revealed that the mono-deprotonated (HL) ligand acted as a bidentate ligand, which bound to both Zn(II) and Cu(II) ions via the nitrogen atom of the amine (N–H) and the hydroxyl (O–H) groups through the deprotonated oxygen atom. Formation constants and thermal analysis indicated that both metal complexes are stable up to 100 °C with thermodynamically favored chemical reactions. The Cu(II) complex showed antibacterial activities with the zones of inhibition of 20.90 ± 2.00 mm against Pseudomonas aeruginosa, 19.69 ± 0.71 mm against Staphylococcus aureus, and 18.58 ± 1.04 mm against Streptococcus pyogenes. These results are relatively higher compared with the Zn(II) complex at the same concentration. The minimum inhibitory concentration (MIC) results for the complexes also showed similar trends against the three bacteria. On the other hand, radical scavenging activities of both Cu(II) and Zn(II) complexes showed half-maximal inhibitory concentrations (IC(50)) of 4.72 and 8.2 μg/mL, respectively, while ascorbic acid (a positive control) has a value of 4.28 μg/mL. The Cu(II) complex exhibited better communication with the positive control, indicating its potential use for biological activities. The calculated and in silico molecular docking results also strongly support the experimental results. American Chemical Society 2022-07-19 /pmc/articles/PMC9352163/ /pubmed/35936450 http://dx.doi.org/10.1021/acsomega.2c02205 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Damena, Tadewos
Alem, Mamaru Bitew
Zeleke, Digafie
Desalegn, Tegene
Eswaramoorthy, Rajalakshmanan
Demissie, Taye B.
Novel Zinc(II) and Copper(II) Complexes of 2-((2-Hydroxyethyl)amino)quinoline-3-carbaldehyde for Antibacterial and Antioxidant Activities: A Combined Experimental, DFT, and Docking Studies
title Novel Zinc(II) and Copper(II) Complexes of 2-((2-Hydroxyethyl)amino)quinoline-3-carbaldehyde for Antibacterial and Antioxidant Activities: A Combined Experimental, DFT, and Docking Studies
title_full Novel Zinc(II) and Copper(II) Complexes of 2-((2-Hydroxyethyl)amino)quinoline-3-carbaldehyde for Antibacterial and Antioxidant Activities: A Combined Experimental, DFT, and Docking Studies
title_fullStr Novel Zinc(II) and Copper(II) Complexes of 2-((2-Hydroxyethyl)amino)quinoline-3-carbaldehyde for Antibacterial and Antioxidant Activities: A Combined Experimental, DFT, and Docking Studies
title_full_unstemmed Novel Zinc(II) and Copper(II) Complexes of 2-((2-Hydroxyethyl)amino)quinoline-3-carbaldehyde for Antibacterial and Antioxidant Activities: A Combined Experimental, DFT, and Docking Studies
title_short Novel Zinc(II) and Copper(II) Complexes of 2-((2-Hydroxyethyl)amino)quinoline-3-carbaldehyde for Antibacterial and Antioxidant Activities: A Combined Experimental, DFT, and Docking Studies
title_sort novel zinc(ii) and copper(ii) complexes of 2-((2-hydroxyethyl)amino)quinoline-3-carbaldehyde for antibacterial and antioxidant activities: a combined experimental, dft, and docking studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352163/
https://www.ncbi.nlm.nih.gov/pubmed/35936450
http://dx.doi.org/10.1021/acsomega.2c02205
work_keys_str_mv AT damenatadewos novelzinciiandcopperiicomplexesof22hydroxyethylaminoquinoline3carbaldehydeforantibacterialandantioxidantactivitiesacombinedexperimentaldftanddockingstudies
AT alemmamarubitew novelzinciiandcopperiicomplexesof22hydroxyethylaminoquinoline3carbaldehydeforantibacterialandantioxidantactivitiesacombinedexperimentaldftanddockingstudies
AT zelekedigafie novelzinciiandcopperiicomplexesof22hydroxyethylaminoquinoline3carbaldehydeforantibacterialandantioxidantactivitiesacombinedexperimentaldftanddockingstudies
AT desalegntegene novelzinciiandcopperiicomplexesof22hydroxyethylaminoquinoline3carbaldehydeforantibacterialandantioxidantactivitiesacombinedexperimentaldftanddockingstudies
AT eswaramoorthyrajalakshmanan novelzinciiandcopperiicomplexesof22hydroxyethylaminoquinoline3carbaldehydeforantibacterialandantioxidantactivitiesacombinedexperimentaldftanddockingstudies
AT demissietayeb novelzinciiandcopperiicomplexesof22hydroxyethylaminoquinoline3carbaldehydeforantibacterialandantioxidantactivitiesacombinedexperimentaldftanddockingstudies